ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SALV Salvarx Group Plc

4.50
0.00 (0.00%)
18 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Salvarx Group Plc LSE:SALV London Ordinary Share IM00BZ4SS228 ORD 2.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.50 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Salvarx Share Discussion Threads

Showing 26 to 46 of 600 messages
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
09/8/2016
12:41
I'm in for a few of these today! Hoping the company succeeds very much.
moormoney
30/7/2016
20:56
A few months old, but still of interest:

"Jim Mellon-backed biotech to join Aim
SalvaRX working on treatments using T-cells to attack tumours
MARCH 21, 2016
by: Andrew Ward, Pharmaceuticals Correspondent
An experimental cancer drug discovered at Oxford university is the focus of a new UK biotech company to be listed in London this week led by two veterans of Bristol-Myers Squibb, the large US pharmaceuticals group."


P.S. Please note the following thread which may be of interest:

"THE REVERSE TAKEOVERS & SHELLS THREAD (RTO)"

hedgehog 100
05/7/2016
18:15
Is this a dead cat bounce heading for a fall down towards 6p...
halfpenny
05/7/2016
18:14
Why buy this stock...... Nobody has provided a strong case.....they received grants but can they deliver..
halfpenny
04/7/2016
14:43
This is the second leg down so will we have a third, remember they did buy 3 Leg !!

6p getting closer, let's see....

rocketblast
02/7/2016
18:14
you need to value it based on facts.

Revenue: 0
Risk: High
Rewards: Unknown


result may get in at 6p for the risk....im waiting...no hurry
remember... never catch a falling knife especially one with double sharp sides..ouch

halfpenny
28/6/2016
14:10
is it worth it at 24p?

clearly wasn't at 34p.

runwaypaul
09/5/2016
12:05
It is worth adding to your shareholdings here. A major breakthrough will see the company's value multiply many times.
kingston78
08/5/2016
15:59
SalvRx owns 10% of Intensity Therapeutics .... Looking forward to tomorrow and whether and if so how the market reacts to this article.

Interesting that there were buyers around last week at the full offer price - which might indicate there really aren't any sellers

edcrane
08/5/2016
14:28
Intensity Therapeutics;
doodlebug4
21/4/2016
15:37
The CEO is over from America next week and we should see some share price action.
wiseacre
05/4/2016
10:24
dropping like stone right now.
sucking em in@36 spitting em out @28
AT man stripping the Bid

runwaypaul
31/3/2016
14:06
With so little stock out there you need to be buying at the base levels
kmann
30/3/2016
10:52
The share price is moving up towards the 35.5 p subscription price, which should act as a base. This company has great potential and I always follow the man who leads from the front. A successful businessman will always make his new ventures successful. He has his reputation to protect.
kingston78
30/3/2016
09:22
One to buy before the crowd. Blockbuster potential.
kmann
29/3/2016
21:28
VELA took its stake up from .64% to over 3% last week unless I'm mistaken?

DC

daicaprice
22/3/2016
13:01
As stig says, cashed up to Phase II. They can attract research funding too.

IP can be worth a pretty penny, ask the makers of asprin, viagra etc. Thats where were heading. Reducing cancer to a chronic condition. Always a premium for IP. ARM another good example.

kmann
22/3/2016
12:24
they have cash of c£3.5m

market cap over £12.5m

soul limbo
22/3/2016
12:11
Oxford Uni not as hot as Cambridge I think
the stigologist
22/3/2016
10:53
I have a feeling some of JMs mates are heavy backers too, the kind who know what success looks and tastes like.

The concept here is good, and Oxford University have enough clout too.

kmann
22/3/2016
10:14
Better be quick then...http://technology.inquirer.net/47366/us-interested-in-cuban-lung-cancer-vaccines
hitch19
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com